POLAREAN IMAG.LS-00037 (F:8ZF) — Market Cap & Net Worth
Market Cap & Net Worth: POLAREAN IMAG.LS-00037 (8ZF)
POLAREAN IMAG.LS-00037 (F:8ZF) has a market capitalization of $1.04 Million (€893.10K) as of May 5, 2026. Listed on the F stock exchange, this Germany-based company holds position #30176 globally and #2662 in its home market, demonstrating a 200.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying POLAREAN IMAG.LS-00037's stock price €0.00 by its total outstanding shares 1207032781 (1.21 Billion).
POLAREAN IMAG.LS-00037 Market Cap History: 2021 to 2025
POLAREAN IMAG.LS-00037's market capitalization history from 2021 to 2025. Data shows change from $903.13 Million to $2.12 Million (-72.68% CAGR).
POLAREAN IMAG.LS-00037 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how POLAREAN IMAG.LS-00037's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 8ZF by Market Capitalization
Companies near POLAREAN IMAG.LS-00037 in the global market cap rankings as of May 5, 2026.
Key companies related to POLAREAN IMAG.LS-00037 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #141 globally with a market cap of $155.56 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #208 globally with a market cap of $112.79 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #230 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Medtronic PLC (NYSE:MDT): Ranked #236 globally with a market cap of $102.56 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #141 | Abbott Laboratories | NYSE:ABT | $155.56 Billion | $89.46 |
| #208 | Stryker Corporation | NYSE:SYK | $112.79 Billion | $294.73 |
| #230 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #236 | Medtronic PLC | NYSE:MDT | $102.56 Billion | $80.00 |
POLAREAN IMAG.LS-00037 Historical Marketcap From 2021 to 2025
Between 2021 and today, POLAREAN IMAG.LS-00037's market cap moved from $903.13 Million to $ 2.12 Million, with a yearly change of -72.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €2.12 Million | +200.00% |
| 2024 | €705.57K | -98.55% |
| 2023 | €48.68 Million | -94.25% |
| 2022 | €846.69 Million | -6.25% |
| 2021 | €903.13 Million | -- |
End of Day Market Cap According to Different Sources
On May 4th, 2026 the market cap of POLAREAN IMAG.LS-00037 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $1.04 Million USD |
| MoneyControl | $1.04 Million USD |
| MarketWatch | $1.04 Million USD |
| marketcap.company | $1.04 Million USD |
| Reuters | $1.04 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About POLAREAN IMAG.LS-00037
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent ind… Read more